Global Med Technologies(R), Inc.'s Division, Wyndgate Technologies(R), Continues to Partner With Large Donor Centers
November 08 2006 - 9:00AM
PR Newswire (US)
Indiana Blood Center Selects Wyndgate's SafeTrace(R) Donor
Management System DENVER, Nov. 8 /PRNewswire-FirstCall/ -- Wyndgate
Technologies(R), a division of Global Med Technologies(R), Inc.,
(OTC:GLOB) (BULLETIN BOARD: GLOB) continues to distinguish itself
as a trusted partner to large donor center clients by announcing
today that it has partnered with Indiana Blood Center (IBC) for its
SafeTrace(R) donor management system. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO ) IBC is
one of the nations largest independent blood banking institutes,
collecting approximately 150,000 donations per year. Through these
donations, IBC provides blood products to 48 hospitals throughout
the state of Indiana supporting more than two million (2,000,000)
Indiana residents. Wyndgate's SafeTrace system will assist IBC in
accurately and efficiently managing the mass of information
necessary to successfully run a large donor center, including donor
scheduling, blood product manufacturing and infectious disease
testing as well as blood product inventory, shipping and billing.
In addition, SafeTrace will enable IBC to continue meeting the
highest standards in the industry -- such as the ISBT 128 blood
component labeling standard required to be implemented in 2008.
Byron B. Buhner, President of Indiana Blood Center, says, "We are
dependent on sophisticated information technology systems for
enhancing our ability to work efficiently and to assure continued
growth. We are pleased that Wyndgate's system will meet our needs
now and in the future." Thomas F. Marcinek, President of Wyndgate
Technologies, commented, "Indiana Blood Center is vital in
supporting hospitals and communities across the state. IBC
recognizes this important role and its need for a robust system
that can fulfill its current management needs as well as help it
continue to rise to ever higher standards." Mr. Marcinek continued,
"IBC did not take its decision regarding a new blood management
system lightly. IBC examined the entire market and took a
considerable amount of time to seriously investigate its leading
choices. In light of this thoroughness, Wyndgate is particularly
proud to have been selected by IBC, which demonstrated the blood
center's confidence in SafeTrace being able to meet IBC's needs.
Wyndgate expanded its customer base with clients of varying sizes
this year, and it is extremely gratifying to see our products
continue to meet the diverse needs of the blood industry." About
Indiana Blood Center: Indiana Blood Center (IBC) is a non-profit
community service organization licensed by the FDA and the Indiana
State Department of Health, and accredited by AABB. Founded in
1952, IBC takes seriously its mission to "provide a continuous,
safe and adequate supply of blood products and testing services,
first to the people in our own communities, then wherever our blood
products and testing services are needed." IBC relies on the
generosity of its donors to supply more than 550 units of blood
each day to 48 Indiana hospitals. About Global Med Technologies,
Inc. Global Med Technologies, Inc. is an international e-Health
medical information technology company providing information
management software products and services to the healthcare
industry. Its Wyndgate Technologies division is a leading supplier
of information management systems to U.S. and international blood
centers and hospital transfusion centers. Each year, Wyndgate's
products and services manage more than eight million blood
components, representing over 27% of the U.S. blood supply.
Wyndgate's products are being used in Canada and sub-Saharan
Africa, and are being implemented in the Caribbean. Together, the
SafeTrace Tx(R)* advanced transfusion management system and the
SafeTrace(R) donor management system provide Vein-to-Vein(R)
tracking from donor collection to patient transfusion. For more
information about Global Med's products and services, please call
800-WYNDGATE or visit http://www.globalmedtech.com/,
http://www.peoplemed.com/ and http://www.wyndgate.com/. This news
release may include statements that constitute forward-looking
statements, usually containing the words "believe," "estimate,"
"project," "expects" or similar expressions. These statements are
made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. Forward-looking
statements inherently involve risks and uncertainties that could
cause actual results to differ materially from the forward-looking
statements. By making these forward-looking statements, the Company
undertakes no obligation to update these statements for revisions
or changes after the date of this news release. * Patent Pending
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies,
Inc. CONTACT: Michael I. Ruxin, M.D., of Global Med Technologies,
Inc., +1-303-238-2000 Web site: http://www.peoplemed.com/ Web site:
http://www.wyndgate.com/ Web site: http://www.globalmedtech.com/
Copyright